LEADER TRIPLE ANTIBIOTIC (CARDINAL HEALTH)
Welcome to the PulseAid listing for the LEADER TRIPLE ANTIBIOTIC drug offered from CARDINAL HEALTH. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | CARDINAL HEALTH |
| NON-PROPRIETARY NAME: | BACITRACIN, NEOMYCIN SULFATE, POLYMYXIN-B SULFATE |
| SUBSTANCE NAME: | BACITRACIN; NEOMYCIN; POLYMYXIN B SULFATE |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | TOPICAL |
| DOSAGE FORM: | OINTMENT |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH FINAL |
| START MARKETING DATE: | 2012-03-01 |
| END MARKETING DATE: | 0000-00-00 |
LEADER TRIPLE ANTIBIOTIC HUMAN OTC DRUG Details:
| Item Description | LEADER TRIPLE ANTIBIOTIC from CARDINAL HEALTH |
| LABELER NAME: | CARDINAL HEALTH |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 400; 3.5; 5000([iU]/g; mg/g; [iU]/g) |
| START MARKETING DATE: | 2012-03-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 37205-273_4269f57a-b6b3-4594-98fc-967f6e47df63 |
| PRODUCT NDC: | 37205-273 |
| APPLICATION NUMBER: | part333B |
Other BACITRACIN; NEOMYCIN; POLYMYXIN B SULFATE Pharmaceutical Manufacturers / Labelers:
